|
ALMS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69453340248538E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.0345002632306E-10 |
| Normal-vs-Stage2 |
7.00109999973719E-08 |
| Normal-vs-Stage3 |
8.88480400362823E-11 |
| Normal-vs-Stage4 |
6.04279959404153E-10 |
| Stage1-vs-Stage2 |
2.514000E-01 |
| Stage1-vs-Stage3 |
2.562200E-01 |
| Stage1-vs-Stage4 |
4.946000E-02 |
| Stage2-vs-Stage3 |
7.567600E-01 |
| Stage2-vs-Stage4 |
7.068000E-01 |
| Stage3-vs-Stage4 |
4.316200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.13065154198011E-13 |
| Normal-vs-AfricanAmerican |
4.437400E-03 |
| Normal-vs-Asian |
1.53939999969488E-07 |
| Caucasian-vs-AfricanAmerican |
1.159770E-01 |
| Caucasian-vs-Asian |
9.518400E-01 |
| AfricanAmerican-vs-Asian |
1.598240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.46629955241917E-10 |
| Normal-vs-Female |
1.18319798403377E-11 |
| Male-vs-Female |
1.461840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.00370001199224E-09 |
| Normal-vs-Age(41-60Yrs) |
1.40660039171792E-10 |
| Normal-vs-Age(61-80Yrs) |
2.72640021670156E-10 |
| Normal-vs-Age(81-100Yrs) |
3.611700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.519000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.458200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.637560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.893800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.829000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.973000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.151810E-02 |
| Classical-VS-Follicular |
4.602200E-03 |
| Classical-VS-Other |
3.859800E-01 |
| Classical-VS-Normal |
1.79960000012969E-07 |
| Tall-VS-Follicular |
9.181000E-01 |
| Tall-VS-Other |
9.099200E-01 |
| Tall-VS-Normal |
2.58279997389366E-09 |
| Follicular-VS-Other |
9.320400E-01 |
| Follicular-VS-Normal |
1.53379975387224E-10 |
| Other-VS-Normal |
6.422300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91131571575443E-13 |
| Normal-vs-N1 |
8.11220002283619E-09 |
| N0-vs-N1 |
6.590400E-01 |
|
|
